Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock
Clinical trial NCT07583446 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07583446
- Sponsor
- Seismic Pharmaceuticals Operations LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-12-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.